(1980–2016) RA – Treatment Poster IV

Monday, November 14, 2022

1:00 PM – 3:00 PM Eastern Time

Location: Virtual Poster Hall

All of the relevant financial relationships listed for faculty have been mitigated.

Poster abstract session.

Presentations:

1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

Anti-S1 Antibody Levels Two Weeks After the Second Dose of an mRNA anti-SARS-CoV2 Vaccine Predict Maintenance of a Potent Neutralizing Activity over 24 Weeks in RA Patients
Abstract Poster Presenter: Andrea Rubbert-Roth, MD – Cantonal Hospital St Gallen
1:00 PM – 3:00 PM Eastern Time

Malignancies Risk in Rheumatoid Arthritis Patients Treated with Tofacitinib or TNF Inhibitors, a National Study: RELATION Study
Abstract Poster Presenter: Jacques-Eric Gottenberg, PhD – CHU
1:00 PM – 3:00 PM Eastern Time

The BEGIN Study: A Double-blind, Multi-center, Two-part, Randomized, Placebo-controlled Study of the Safety, Tolerability, and Efficacy of 4 Weeks of Treatment with AP1189 in Early Rheumatoid Arthritis (RA) Patients with Active Joint Disease
Abstract Poster Presenter: Thomas Jonassen, MD – SynAct Pharma
1:00 PM – 3:00 PM Eastern Time

Early-stage Rheumatoid Arthritis Patients with High Levels of Type III Collagen Are Less Likely to Respond to Anti-IL6R Treatment
Abstract Poster Presenter: Sofie Falkenløve Madsen, MSc – University of Copenhagen / Nordic Bioscience
1:00 PM – 3:00 PM Eastern Time

Prednisone Use and the Incidence of Hyperglycemia or Diabetes in Patients with Rheumatoid Arthritis; A 10-year Sub Analysis of the BeSt Study
Abstract Poster Presenter: Joy Pol, MD – Leiden University Medical Center
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

Predictors of Flare in the RHEUmatoid Arthritis Medication TAPering (RHEUMTAP) Cohort
Abstract Poster Presenter: Nada Alrifai, MD – Allegheny Health Network
1:00 PM – 3:00 PM Eastern Time

Artificial Intelligence Applied to Transcriptomics Profiling of Synovial Tissue Biopsies Accurately Predicts Rheumatoid Arthritis Patients Who Will Respond or Be Refractory to Standard Biological Treatments
Abstract Poster Presenter: Giorgio Casaburi, PhD, MSc – Exgen Inc.
1:00 PM – 3:00 PM Eastern Time

Mice Do Not Develop CIA: Knocking out of Kv1.3 Renders CD4+T_EMCells Resistant to Activation
Abstract Poster Presenter: Siba Raychaudhuri, MD – UC Davis, School of Medicine/ VA Medical Center, Sacramento
1:00 PM – 3:00 PM Eastern Time

Burden of Pain for Patients in the CorEvitas^TM Rheumatoid Arthritis Registry
Abstract Poster Presenter: Joshua Baker, MD, MS – University of Pennsylvania
1:00 PM – 3:00 PM Eastern Time

Changes in Omega-6- and Omega-3-Derived Bioactive Lipids in Response to an Anti-Inflammatory Dietary Intervention
Abstract Poster Presenter: Esha Lal, BS – UCSD School of Medicine
1:00 PM – 3:00 PM Eastern Time

Is Glucocorticoid Bridging Associated with Later Glucocorticoid and Biological DMARD Use in Patients with Rheumatoid Arthritis?
Abstract Poster Presenter: Lotte van Ouwerkerk, MD – Leiden University Medical Center
1:00 PM – 3:00 PM Eastern Time

Baricitinib Improves Bone Biomechanical Properties in Rheumatoid Arthritis (RA) – Results of a Prospective Interventional Study
Abstract Poster Presenter: Arnd Kleyer, MD – University Hospital Erlangen
1:00 PM – 3:00 PM Eastern Time

Individual Patient Data Meta-analysis on Continued Use of Glucocorticoids After Their Use as Bridging Therapy in Patients with Rheumatoid Arthritis
Abstract Poster Presenter: Lotte van Ouwerkerk, MD – Leiden University Medical Center
1:00 PM – 3:00 PM Eastern Time

Effects of Short Chain Fatty Acid Supplementation in Modulation of Gut Microbiome and T-Regulatory Cells in Health and New Onset Rheumatoid Arthritis
Abstract Poster Presenter: Rebecca Blank, MD, PhD – NYU
1:00 PM – 3:00 PM Eastern Time

Effect of a Lifestyle Program Based on a Whole Food Plant-based Diet, Physical Activity, and Stress Management in Patients with Rheumatoid Arthritis: A Randomized Controlled Trial
Abstract Poster Presenter: Wendy Walrabenstein, MA – Amsterdam UMC
1:00 PM – 3:00 PM Eastern Time

Patient-Reported Outcomes in Rheumatoid Arthritis Correlate with Clinical Disease Activity Index Response in the Study to Accelerate Information of Molecular Signatures (AIMS)
Abstract Poster Presenter: Vibeke Strand, MD, FACP, MACR – Stanford University School of Medicine, Palo Alto CA
1:00 PM – 3:00 PM Eastern Time

Tapering of Long-term, Low Dose Glucocorticoids in Senior Rheumatoid Arthritis Patients: Follow up of the Pragmatic, Multicentre, Placebo-controlled GLORIA Trial
Abstract Poster Presenter: Abdullah Almayali, BSc – Vrije Universiteit Amsterdam
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

Do SMS and Email Reminders Increase the Rate of Seasonal Influenza Vaccination in RA Patients Treated with Biologics: A Nested Randomized Controlled Trial Within the ART Registry?
Abstract Poster Presenter: Raphaele Seror, MD, PhD – university hospital Paris Saclay
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

Which Route and Dose of Corticosteroids Is Most Effective in Inducing Remission in Early Rheumatoid Arthritis? A Systematic Literature Review and Meta-analysis
Abstract Poster Presenter: Nicola Gullick, FRCP – University Hospital Coventry & Warwickshire
1:00 PM – 3:00 PM Eastern Time

Comparison of Treatment and Disease Activity in the Early Stage of Onset in Patients with Elderly-onset vs Younger-onset Rheumatoid Arthritis Using Data of National Database of Rheumatic Diseases in Japan (NinJa)
Abstract Poster Presenter: Toshihiro Matsui, MD, PhD – NHO Sagamihara National Hospital
1:00 PM – 3:00 PM Eastern Time

Healthcare Resource Utilization and Economic Burden of Patients with Adequate and Inadequate Responses to Advanced Therapies for Rheumatoid Arthritis in Japan
Abstract Poster Presenter: Kei Ikeda, MD, PhD – Chiba University Hospital
1:00 PM – 3:00 PM Eastern Time

Rheumatoid Arthritis Associated Lymphoproliferative Disorders: Current Features and It’s Changing Pattern Due to the Influence of Anti-rheumatic Drugs
Abstract Poster Presenter: YOSHIHIKO HOSHIDA, MD – National Hospital Organization Osaka Minami Medical Center
1:00 PM – 3:00 PM Eastern Time

A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Mechanistic Insight and Dosage Optimization Study of the Efficacy and Safety of Dazodalibep (VIB4920/HZN4920) in Patients with Rheumatoid Arthritis Having Inadequate Response to Conventional/Biological DMARDs
Abstract Poster Presenter: Alan J. Kivitz, MD – Altoona Center for Clinical Research
1:00 PM – 3:00 PM Eastern Time

Long-term Outcome of a Treat-to-target Strategy in Elderly-onset Rheumatoid Arthritis with Chronic Lung Diseases
Abstract Poster Presenter: Manami Nomura, MS – Tokyo Medical and Dental University
1:00 PM – 3:00 PM Eastern Time

Lowering Expectations: Glucocorticoid Tapering Among Veterans with Rheumatoid Arthritis Achieving Low Disease Activity on Stable Biologic Therapy
Abstract Poster Presenter: Beth I. Wallace, MD, MS – Michigan Medicine, VA Ann Arbor Healthcare System
1:00 PM – 3:00 PM Eastern Time

More Meticulously Following Treat-to-target in RA Does Not Lead to Less Radiographic Progression: A Longitudinal Analysis in BIODAM
Abstract Poster Presenter: Sofia Ramiro, MD, PhD – Leiden University Medical Center
1:00 PM – 3:00 PM Eastern Time

Predictors of Remission in Rheumatoid Arthritis Patients Treated with Biologics: A Systematic Review and Meta-analysis
Abstract Poster Presenter: Yasmin Khader, MD – University of Toledo
1:00 PM – 3:00 PM Eastern Time

Drug Free Remission in Rheumatoid Arthritis: Data from the Randomized Controlled ARCTIC REWIND Trial
Abstract Poster Presenter: Siri Lillegraven, MD, PhD, MPH – Diakonhjemmet Hospital
1:00 PM – 3:00 PM Eastern Time

WITHDRAWN
1:00 PM – 3:00 PM Eastern Time

JAK Selectivity Did Not Affect to the Incidence of Malignancies in the Real-World Setting: Data from a Multicenter Observational Study in Japan
Abstract Poster Presenter: Tomohisa Uchida, MD – National Hospital Organization Ureshino Medical Center
1:00 PM – 3:00 PM Eastern Time

Safety and Efficacy Associated with Long-Term Low Dose Glucocorticoids in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
Abstract Poster Presenter: Andriko Palmowski, MD – Charité - Universitätsmedizin Berlin
1:00 PM – 3:00 PM Eastern Time

Vascular Effect of Treat to Target in Early Rheumatoid Arthritis Patients - A 5-year Prospective Study
Abstract Poster Presenter: Huan Meng, PhD – The Faculty of Medicine, CUHK